A population of CD133 þ Lin À CD45 À very small embryonic/ epiblast-like stem cells (VSELs) has been purified by multiparameter sorting from umbilical cord blood (UCB). To speed up isolation of these cells, we employed anti-CD133-conjugated paramagnetic beads followed by staining with Aldefluor to detect aldehyde dehydrogenase (ALDH) activity; we subsequently sorted CD45 À /GlyA À /CD133 þ /ALDH high and CD45 À / GlyA À /CD133 þ /ALDH low cells, which are enriched for VSELs, and CD45 þ /GlyA /CD133 þ /ALDH high and CD45 þ /GlyA À / CD133 þ /ALDH low cells, which are enriched for hematopoietic stem/progenitor cells (HSPCs). Although freshly isolated CD45 À VSELs did not grow hematopoietic colonies, the same cells, when activated/expanded over OP9 stromal support, acquired hematopoietic potential and grew colonies composed of CD45 þ hematopoietic cells in methylcellulose cultures. We also observed that CD45 À /GlyA À /CD133 þ /ALDH high VSELs grew colonies earlier than CD45 À /GlyA À /CD133 þ /ALDH low VSELs, which suggests that the latter cells need more time to acquire hematopoietic commitment. In support of this possibility, real-time polymerase chain reaction analysis confirmed that, whereas freshly isolated CD45 À /GlyA À /CD133 þ /ALDH high VSELs express more hematopoietic transcripts (for example, c-myb), CD45 À /GlyA À /CD133 þ /ALDH low VSELs exhibit higher levels of pluripotent stem cell markers (for example, Oct-4). More importantly, hematopoietic cells derived from VSELs that were co-cultured over OP9 support were able to establish human lympho-hematopoietic chimerism in lethally irradiated non-obese diabetic/severe combined immunodeficiency mice 4-6 weeks after transplantation. Overall, our data suggest that UCB-VSELs correspond to the most primitive population of HSPCs in UCB.
Introduction
Hematopoietic stem cells (HSCs) can be purified from bone marrow (BM), umbilical cord blood (UCB) and mobilized peripheral blood by employing (i) characteristic stem cell antigens (for example, CD34 and CD133), (ii) the absence of lineage differentiation markers (Lin À ), (iii) high expression of ALDH and (iv) low accumulation of Hoechst 3342 (Hoe3342 low ), Pyronin Y (Pyronin Y low ) or Rhodamine 123 (Rh123 low ) dyes. 1 A combination of signaling lymphocyteactivating molecule markers (CD150 þ , CD48 À and CD244 À ) has also been recently proposed for discriminating primitive hematopoietic stem/progenitor cell (HSPC) populations. 2 Nevertheless, the phenotype of most primitive HSCs, known as long-term repopulating HSCs (LT-HSCs), is not very well defined. According to their definition, LT-HSCs establish longlasting, stable chimerism after hematopoietic transplantation and, as proposed, reside in human BM among CD34 À CD38 À Lin À3 or CD133 þ Lin À ALDH high cells. 4 These most primitive HSCs display only limited clonogenic potential in routine assays in vitro; however, they are able to engraft and establish hematopoiesis in experimental animals. 5, 6 Similar cells can be detected in UCB by employing direct intra-bone marrow transplantation and have been identified among CD34 À flt À Lin À cells. 7 Recently, we identified in murine BM and fetal liver a population of very small embryonic/epiblast-like (VSEL) stem cells that (i) are smaller than erythrocytes, (ii) express SSEA-1 þ / Oct-4 þ /Sca-1 þ /CXCR4 þ /Lin À /CD45 À , (iii) respond to an SDF-1 gradient and (iv) have high nuclear:cytoplasm ratio and primitive euchromatin. 8 Murine VSELs do not reveal hematopoietic activity immediately after isolation, but acquire hematopoietic potential similar to stem cells from established embryonic stem cell (ESCs) lines and inducible pluripotent stem cells following co-culture/activation over OP9 stroma. 9 On the basis of these findings, we hypothesized that in murine BM they fulfill the functional criteria for LT-HSCs. 9 As shown recently, these cells are also early in the mesenchymal lineage hierarchy. 10 We recently identified corresponding populations of SSEA-4 þ /Oct-4 þ /CD133 þ /CD34 þ /CXCR4 þ /Lin À /CD45 À cells in UCB that are (i) slightly smaller than erythrocytes, (ii) have high nuclear:cytoplasm ratio and euchromatin and (iii) display transcription factor signature of pluripotent stem cells, including Oct-4 and Nanog. 11 By employing fluorescenceactivated cell sorting (FACS), followed by quantitative genetic analysis, we found that CD45 À /Lin À /CD133 þ , CD45 À /Lin À / CD34 þ and CD45 À /Lin À /CXCR4 þ fractions of UCB cells are significantly enriched in VSELs. 12 However, molecular analysis revealed that the subpopulation of CD45 À /Lin À /CD133 þ cells, a rare CD45 À /Lin À cell population, possesses the highest expression of pluripotency markers. On the basis of this, we hypothesized that CD133 antigen may be the most optimal surface marker to identify the most primitive VSELs. The presence of similar cells was recently confirmed in UCB, human BM and mobilized peripheral blood by other groups. 13, 14 In this study, to attain a faster process to avoid timeconsuming multiparameter sorting procedure for isolating VSELs from UCB, we employed anti-CD133 paramagnetic beads, followed by staining with Aldefluor, a fluorescent dye to detect ALDH, and sorted CD45 À /GlyA À /CD133 þ /ALDH high and CD45 À / GlyA À /CD133 þ /ALDH low subfractions of VSELs and CD45 þ / GlyA À /CD133 þ /ALDH high and CD45 þ /GlyA À /CD133 þ /ALDH low subfractions of HSPCs. We found that while freshly isolated VSELs did not grow colonies in vitro, these cells, if immediately expanded over OP9 stromal cells, acquired hematopoietic potential and grew colonies composed of CD45 þ cells. Furthermore, although CD45 þ cells gave raise to hematopoietic colonies after the first replating, the formation of colonies by CD45 À /GlyA À /CD133 þ /ALDH low VSELs was somewhat delayed, which suggests that they require more time to attain hematopoietic commitment. In parallel, real-time polymerase chain reaction (PCR) analysis confirmed that while freshly isolated CD45 À /GlyA À /CD133 þ /ALDH high VSELs express more hematopoietic transcripts, CD45 À /GlyA À /CD133 þ /ALDH low VSELs exhibit higher levels of pluripotent stem cell transcription factors. Finally, in in vivo transplants into non-obese diabetic/ severe combined immunodeficiency (NOD/SCID) mice, we observed that both CD45 À /GlyA À /CD133 þ /ALDH high and CD45 À /GlyA À /CD133 þ /ALDH low VSELs cultured over OP9 cells give rise to human lympho-hematopoietic chimerism as assayed 4-6 weeks after transplantation. Taking all of these observations into account, we propose that, like murine BM-derived VSELs, human UCB-derived CD45 À VSELs correspond to a population of the most primitive LT-HSCs.
Materials and methods

Isolation and FACS sorting of VSELs from UCB
This study was performed in accordance with the guidelines of the local ethical and biohazard authorities at the University of Louisville School of Medicine (Louisville, KY, USA). Clinicalgrade UCB research units were shipped from Cleveland Cord Blood Center and were treated with 1 Â BD Pharm Lyse Buffer (BD Pharmingen, San Jose, CA, USA) for 15 min at room temperature to remove RBCs and washed twice in phosphatebuffered saline. A single-cell suspension of total nucleated cells obtained from clinical UCB samples was treated with antibodies against CD133 antigen-coated immunomagnetic beads and separated by using a MACS Separator (Miltenyi Biotec GmBH, Bergisch Gladbach, Germany) to reduce cell numbers before cell sorting. The CD133 þ cell fraction was reacted with the Aldefluor Kit reagent (StemCell Tech., Tukwila, WA, USA) for detecting ALDH. After the ALDH enzyme reaction, cells were washed and resuspended in cold Aldefluor buffer (StemCell Tech.) and maintained on ice during all subsequent manipulations. Cells were incubated with phycoerythrin-conjugated murine anti-human CD235a (clone GA-R2; BD Biosciences, Franklin Lakes, NJ, USA), phycoerythrin-CY7-CD45 (clone HI30; BD Biosciences) and allophycocyanin-conjugated CD133/2 (Miltenyi Biotec GmBH). Cells were washed and resuspended in cold Aldefluor buffer and sorted by MoFlo sorter (Dako, Burlingame, CA, USA) to obtain populations enriched in VSELs (CD45 À /GlyA À /CD133 þ /ALDH high and CD45/GlyA À / CD133 þ /ALDH low ) as well as for HSPCs (CD45 þ /GlyA À / CD133 þ /ALDH high and CD45 þ /GlyA À /CD133 þ /ALDH low ).
Ex vivo differentiation of VSELs into hematopoietic cells in primary co-cultures over OP9 stromal cells
Freshly sorted CD45 À /GlyA À /CD133 þ /ALDH high and CD45 À / GlyA À /CD133 þ /ALDH low subfractions of VSELs and CD45 þ / GlyA À /CD133 þ /ALDH high and CD45 þ /GlyA À /CD133 þ / ALDH low subfractions of HSPCs were plated over OP9 cells in a-minimum essential medium with 20% fetal bovine serum (Molecular Probes, Invitrogen, Carlsbad, CA, USA) for 7 days and subsequently trypsinized, washed by centrifugation in a-minimum essential medium and replated in methylcellulosebased medium (StemCell Tech., Vancouver, BC, Canada).
Evaluation of the clonogenic potential of sorted cells in methylcellulose cultures
VSELs or HSPCs freshly isolated from BM or cells harvested from OP9 cultures were plated in methylcellulose-based medium (StemCell Tech.) supplemented with murine stem cell growth factor, interleukin-3, granulocyte-macrophage colony-stimulating factor, flt3, thrombopoietin, erythropoietin and insulin growth factor-2. Cells were cultured for 10 days and the number of colonies formed was scored. Subsequently, methylcellulose cultures were solubilized and trypsinized and the resulting cells were washed by centrifugation in a-minimum essential medium and plated into secondary methylcellulose cultures. Cells were grown in the presence of the same growth factors and replated after 10 days into new methylcellulose cultures.
PCR analysis of gene expression in freshly sorted cells and OP9-expanded cells
Total RNA (from samples of approximately 20 000 cells each) was isolated using the RNeasy Mini Kit (Qiagen Inc., Valencia, CA, USA) and genomic DNA removed using the DNA-free Kit (Applied Biosystems, Foster City, CA, USA). Isolated mRNA was reverse-transcribed with Taqman Reverse Transcription Reagents (Applied Biosystems), according to the manufacturer's instructions. Reverse transcription-PCR was performed using Amplitaq Gold (Applied Biosystems) with one cycle of 8 min at 95 1C; two cycles of 2 min at 95 1C, 1 min at 62 1C and 1 min at 72 1C; 38 cycles of 30 s at 95 1C, 1 min at 62 1C and 1 min at 72 1C; and one cycle of 10 min at 72 1C using sequence-specific primers. Quantitative measurement of target transcript expression was performed by real-time quantitative-PCR using an ABI Prism 7500 Sequence Detection System (Applied Biosystems). cDNA from indicated cells was amplified using SYBR Green PCR Master Mix (Applied Biosystems) and specific primers. All primers were designed with Primer Express software (Applied Biosystems), with at least one primer in each pair containing an exon-intron boundary. The threshold cycle (C t ) was determined and relative quantification of the expression level of target genes was obtained with the 2 ÀDDCt method, using b2-microglobulin as an endogenous control gene and mononuclear cell genes as calibration controls. All primers used in reverse transcriptionand real-time quantitative-PCR are listed in Tables 1 and 2, respectively.
FACS analysis of OP9-expanded cells
Cells cultured over OP9 were plated in methylcellulose to grow hematopoietic colonies. Subsequently, colonies were solubilized and evaluated by FACS (LSRII; BD Biosciences) for the expression of CD45, CD14, GlyA, CD3, CD19 and CD41. For detection of antigens, we employed phycoerythrin-CY7-conjugated murine anti-human antibody for CD45 (clone HI30) and fluorescein-conjugated anti-human lineage marker antibodies for CD14 (clone M5E2), GlyA (clone GLA-R2), CD3 (clone UCHT1), CD19 (clone HIB19) and CD41 (clone HIP2). All antibodies were obtained from BD Biosciences. cells were transplanted into mice by tail vein. Anesthetized transplanted mice were killed 6 weeks after transplantation to evaluate chimerism in BM, PB and spleen. For this analysis, we used the same anti-human antibodies listed above.
Statistical analysis
All data in quantitative chromatin immunoprecipitation and gene expression analyses were analyzed using one-factor analysis of variance with Bonferroni's multiple comparison test. We used the Instat1.14 program (GraphPad Software, La Jolla, CA, USA) and statistical significance was defined as Po0.05 or o0.01.
Results
ALDH activity as a new strategy to purify CD133 þ GlyA À CD45 À UCB-VSELs UCB-VSELs were initially purified from erythrocyte-depleted UCB by multiparameter sorting for a population of CD133 þ CD45 À Lin À cells. This procedure, however, is time consuming and the multiparameter sorting time required to process one entire cord blood unit (B50-100 ml) to isolate rare VSELs from UCB mononuclear cells would take up to 3-4 days.
To establish a more efficient method for VSEL purification from UCB, we employed a three-step isolation strategy ( Figure 1 ) based on the removal of erythrocytes by hypotonic lysis (first step), followed by immunomagnetic separation of CD133 þ cells (second step), followed by FACS-based isolation of CD133 þ GlyA À CD45 À cells after exposure to Aldefluor (third step). The resulting cells may be either ALDH high or ALDH low . The rationale for using lysis buffer to remove erythrocytes was based on our observation that it leads to a higher yield of VSELs than removal of erythrocytes by centrifugation over a Ficoll-Paque gradient. 12 On the other hand, the selection of CD133 antigen for VSEL isolation was based on our previous observation that CD133 þ VSELs are highly enriched for pluripotent stem cell transcription factor expression (for example, Oct-4 and SSEA-4). 12 Inclusion of anti-GlyA antibody was based on the known fact that small erythroblast GlyA þ that are present in UCB do not express CD45 antigen. Thus, selection for CD45 À cells was used to enrich for these cells. Figure 2a shows the isolation strategy of immunomagneticseparated UCB CD133 þ cells based on ALDH activity and CD133, GlyA and CD45 expression. By employing this strategy, we have enriched for VSELs (CD45 À /GlyA À /CD133 þ /ALDH high Figure 1 Three-step strategy for larger-scale preparation of VSELs from UCB. We employ a three-step isolation strategy based on the removal of erythrocytes by hypotonic lysis (first step), followed by immunomagnetic separation of CD133 þ cells (second step), followed by their exposure to Aldefluor and FACS-based isolation of CD133 þ GlyA þ CD45 À or CD133 þ GlyA þ CD45 þ cells that are ALDH high or ALDH low (third step). By employing this strategy, we can isolate VSELs (CD45 À /GlyA À /CD133 þ /ALDH high and CD45/ GlyA À /CD133 þ /ALDH low ) as well as HSPCs (CD45 þ /GlyA À / CD133 þ /ALDH high and CD45 þ /GlyA À /CD133 þ /ALDH low ). Table 1 Sequences of primers employed for (q)RT-PCR analysis
Abbreviation: (q)RT-PCR, real-time quantitative reverse transcription-polymerase chain reaction.
Table 2
Sequences of primers employed for RT-PCR analysis
Abbreviation: RT-PCR, reverse transcription-polymerase chain reaction.
Hematopoietic specification of UCB-derived VSELs J Ratajczak et al and CD45/GlyA À /CD133 þ /ALDH low ) as well as for HSPCs (CD45 þ /GlyA À /CD133 þ /ALDH high and CD45 þ /GlyA À / CD133 þ /ALDH low ). Figure 2b shows these cell fractions as a percentage of total CD133 þ /GlyA À UCB cells. The fractions of CD133 þ cells enriched for CD45 À /GlyA À /CD133 þ /ALDH low and CD45 À /GlyA À /CD133 þ /ALDH high VSELs are the smallest ones (B5 and B10%, respectively). The majority of CD133 þ / GlyA À cells were CD45 þ /GlyA À /CD133 þ /ALDH high HSPCs (B70%), followed by CD45 þ /GlyA À /CD133 þ /ALDH low HSPCs (B15%). The total number of these rare cells per 100 ml of UCB is shown in Table 3 . Both CD45 þ /GlyA À /CD133 þ /ALDH high and CD45 þ /GlyA À /CD133 þ /ALDH low VSELs are 2-3 orders of magnitude less numerous than the CD45 þ fractions of HSPCs.
Molecular characterization of sorted cells
The presence of Oct-4, Nanog and SSEA-1 proteins in UCBsorted CD45 À /GlyA À /CD133 þ /ALDH low VSELs was confirmed by immunohistochemical staining (Figure 3a ). Next, reverse transcription-PCR analysis of gene expression confirmed that CD45 À /GlyA À /CD133 þ /ALDH low VSELs have the highest expression of Oct-4, Scl-2 and HoxB4 (Figures 3b and c) . In contrast, LMO2 expression was highest in CD45 þ /GlyA À / CD133 þ /ALDH high HSPCs. Interestingly, freshly sorted human VSELs and HSCs expressed similar levels of c-myb.
Clonogenic potential in vitro of UCB-derived VSELs
After sorting by FACS from UCB, CD45 À /GlyA À /CD133 þ / ALDH high and CD45 À /GlyA À /CD133 þ /ALDH low and CD45 þ / GlyA À /CD133 þ /ALDH high and CD45 þ /GlyA À /CD133 þ / ALDH low cells were subsequently plated in MethoCult medium supplemented with a cocktail of cytokines and growth factors promoting growth of clonogenic colonies (CFU-C). We observed that while CD45 þ /GlyA À /CD133 þ /ALDH high cells freshly isolated from UCB had the highest clonogenic potential, CD45 À /GlyA À /CD133 þ /ALDH low cells did not grow colonies at all. The clonogenic potential of CD45 À /GlyA À /CD133 þ / ALDH high and CD45 þ /GlyA À /CD133 þ /ALDH high cells was very low (Figure 4a ).
Because in our previous work we observed that, like ESCs and induced inducible pluripotent stem cells, murine VSELs must be co-cultured/primed over OP9 stroma to acquire hematopoietic commitment, 9 we employed a similar strategy for human VSELs. We found that after 7 days UCB-purified VSELs (CD45 À /GlyA À / CD133 þ /ALDH low and CD45 À /GlyA À /CD133 þ /ALDH high ) plated over OP9 cells formed colonies resembling cobblestones (Figure 4b ). Of note, the ability to form cobblestone areas was lower for ALDH low VSELs.
In the next step, cells from these cultures were trypsinized on day 7 and subsequently tested for clonogenic potential in MethoCult cultures. Figure 4c (left panel) shows the number of colonies formed by cells isolated from OP9 stroma cultures that were initiated by all four fractions of sorted UCB cells. The number of plated cells was adjusted to have the same numbers of human cells. We observed a significant increase in the clonogenic potential of UCB-VSELs, in particular, in a population of cells that was initiated by CD45 À /GlyA À /CD133 þ / ALDH high VSELs; however, colonies were also formed by cells initiated from CD45 À /GlyA À /CD133 þ /ALDH low VSELs. The clonogenic potential of cells derived from cultures initiated by UCB-VSELs additionally increased 10 days after they were plated into secondary methylcellulose cultures (Figure 4c , right panel), which suggests that these cells need more time to differentiate along the hematopoietic lineage. Of note, colonies grown in these cultures from VSEL-derived CD45 þ cells were 2-3 times larger than those initiated by HSPC-expanded cells. 10 0 10 0 10 4 10 3 10 2 10 1 10 0 10 4 10 3 10 2 10 1 10 0 10 4 10 3 10 2 10 1 10 0 Figure 2 Gating strategy for FACS sorting of UCB-VSELs and HSCs based on the expression of CD133, CD45 and ALDH activity. (a) UCB nucleated cell populations are stained using monoclonal antibodies against human CD235a (GlyA), CD45 and CD133, and exposed to Aldefluor. Sort gates are established by sequentially gating on FSC vs SSC in region R1, followed by gating to define CD45 À /GlyA À (region R2) and CD45 þ /GlyA À (region R3) populations. Cell populations are also defined based on their ALDH activity. Accordingly, cells are sorted as CD45 À /GlyA À /CD133 þ /ALDH low (region R4) and CD45 À / GlyA À /CD133 þ /ALDH high (region R5) subfractions of VSELs and as CD45 þ /GlyA À /CD133 þ /ALDH low (region 6) and CD45 þ /GlyA À / CD133 þ /ALDH high (region R7) HSC populations. (b) The percentage of all fractions of sorted VSELs (CD45 À ) and HSPCs (CD45 þ ) ALDH high/low among UCB-derived CD133 þ GlyA À cells. The data shown represent the combined results from six independent experiments. Table 3 Total number of VSELs per 100 ml of UCB
Phenotype of cells Total number of cells per 100 ml of UCB
CD45 À /GlyA À /CD133 + /ALDH high B10 3 ( ± 0.3) CD45 À /GlyA À /CD133 + /ALDH low B3.6 Â 10 3 (±0.8) CD45 + /GlyA À /CD133 + /ALDH low B46 Â 10 3 (±2.0) CD45 + /GlyA À /CD133 + /ALDH high B375 Â 10 3 (±12.0)
Abbreviations: VSEL, very small embryonic-like stem cells; UCB, umbilical cord blood.
Hematopoietic specification of UCB-derived VSELs J Ratajczak et al FACS analysis of cells derived from aspirated methylcellulose hematopoietic colonies initiated by VSEL-derived cells revealed that cells in these colonies highly express CD45, CD14, CD3, CD19 and CD41 antigens (Figure 4d ). Interestingly, cells expanded from CD45 À /CD133 þ /ALDH high VSELs were significantly enriched for GlyA þ erythroid precursors.
UCB-VSELs expanded over OP9 cells are able to engraft in NOD/SCID-immunodeficient animals
Finally, the in vivo hematopoietic potential of UCB-derived VSELs expanded over OP9 cultures was tested after transplantation into immunodeficient, sublethally irradiated NOD/SCID mice. However, because no chimerism was observed when freshly sorted, non-OP9-cultured freshly purified VSELs were transplanted (data not shown), we transplanted OP9-primed/ expanded cells.
Accordingly, OP9-primed cultures initiated by the same number of sorted cells were trypsinized after 7 days and cells were injected intravenously. After 6 weeks, mice were killed and human-murine chimerism was evaluated in all major hematopoietic lineages in BM, spleen and peripheral blood by FACS using human-specific antibodies. The highest level of chimerism in BM and spleen in all hematopoietic lineages was achieved after transplantation of CD45 þ /CD133 þ /ALDH high HSPCs ( Figure 5 ). However, we also observed significant chimerism after transplantation of OP9-cultured VSELs.
Discussion
The phenotype of the most primitive human LT-HSCs is still not very well defined and several potential candidate cells have been proposed based on the expression of cell-surface antigens (for example, CD133 þ , CD34 þ , CD38 À and Lin À ), signaling lymphocyte-activating molecules markers and low levels of staining by some fluorescent dyes (for example, Rh123 dull , Pyronin Y low and Hoe 33342 low ). 1,2 A useful detection system for the identification of primitive HSPCs is exposure of cells to Aldefluor, which detects ALDH activity. 15 Aldefluor is a substrate for ALDH, a cytosolic enzyme highly expressed in less-differentiated hematopoietic cells and implicated in resistance to some alkylating agents. 15 Aldefluor in the presence of ALDH becomes modified to the fluorescent molecule that marks ALDH-expressing cells. The Aldefluor-based staining may be combined with other stem cell markers, for example, CD133 antigen. It was reported that human ALDH high /Lin À cells, when transplanted into immunodeficient NOD/SCID mice, robustly reconstitute hematopoiesis. 16 Similar cells were recently also found among populations of human BM-derived CD133 þ /Lin À / ALDH high cells. 4 On the other hand, evidence is accumulating that human hematopoietic tissues (BM or UCB) may contain some rare, primitive HSCs that do not match the phenotype of classical HSCs and do not exhibit in vitro hematopoietic activity immediately after purification. 6 Accordingly, we have shown that human BM contains a population of rare CD34 À Lin À CD38 À HSCs that show poor clonogenic activity in vitro, but in vivo engraft robustly in immunodeficient mice. 6 Similarly, it has been reported that human UCB contains rare, primitive CD34 À flt À Lin À cells that, in contrast to normal adult HSCs, do not engraft after intravenous injection and exhibit hematopoietic potential only after intrabone delivery. 17 More recently, these cells were found to be highly enriched in a CD34 À fraction of UCB cells that were depleted of differentiated cells by a cocktail of antibodies against 18 different lineage markers. 18 Moreover, as all of the phenotypic markers for LT-HSC were proposed and established by employing uncultured cells, one of the recent reports employing ex vivo expansion system combined with in vivo transplants showed that a population of UCB CD133 þ / CD38 À cells resembles the most primitive HSPCs. 19 Thus, the CD133 antigen seems to be a very good marker for the most primitive HSPCs.
Recently, we identified a population of VSELs in murine BM that do not exhibit hematopoietic activity immediately after isolation, but later acquire full hematopoietic potential, including the ability to reconstitute long-term hematopoiesis in lethally irradiated recipients following co-culture/activation over OP9 stroma. 8, 9 On the basis of this, we proposed that in murine BM, these cells fulfill the functional criteria for LT-HSCs. 9 Interestingly, these cells were also identified as precursors of multipotential stromal cells indicative of multipotentiality. 10 A corresponding population of SSEA-4 þ /Oct-4 þ /CD133 þ / CD34 þ /CXCR4 þ /Lin À /CD45 À cells was identified recently by us 11, 12 and others 13, 14 in human UCB, BM and mobilized peripheral blood, and thus we became interested in their potential hematopoietic specification. Because human VSELs are very rare, the processing of one UCB unit by a standard procedure employing multiparameter sorting requires up to 4 days. This is, of course, unacceptable taking into consideration cell viability, the time of sorter usage and the time commitment of a sorter operator.
Thus, our first goal was to develop a faster large-scale isolation protocol. To speed up the procedure for VSEL sorting, we employed (i) hypotonic lysis removal of erythrocytes to obtain UCB nucleated cells, (ii) enrichment for CD133 þ VSELs by immunomagnetic beads and, as a final step, (iii) sorting of VSELs from erythrocyte-depleted/immunomagnetic paramagnetic bead-enriched CD133 þ mononuclear cells by employing staining with Aldefluor combined with anti-CD133 (different epitope) and fluorochrome-conjugated anti-CD45 and anti-GlyA antibodies. By employing this strategy, all four populations of cells (i) CD45 À /GlyA À /CD133 þ /ALDH high , (ii) CD45 À / GlyA À /CD133 þ /ALDH low , (iii) CD45 þ /GlyA À /CD133 þ /ALDH high and (iv) CD45 þ /GlyA À /CD133 þ /ALDH low were sorted and subsequently tested for hematopoietic activity.
We observed that UCB-purified CD45 À /GlyA À /CD133 þ / ALDH high and CD45/GlyA À /CD133 þ /ALDH low VSELs, like their murine counterparts, do not exhibit hematopoietic potential immediately after isolation. However, based on our observations that murine CD45 À VSELs may become HSCs after coculture over OP9 stroma cells, we became interested in whether human CD45 À VSELs may become specified into the hematopoietic lineage as well. In fact, we observed that UCB-derived CD45 À VSELs, like murine VSELs, human ESCs or inducible pluripotent stem cells, become specified into the hematopoietic lineage in co-cultures over an OP9 feeder layer. 20 This robust specification of human UCB-derived CD45 À VSELs is supported by their ability to form hematopoietic colonies in vitro that express pan-hematopoietic CD45 antigen as well as several major lympho-hematopoietic lineage markers (CD41, GlyA, CD14, CD3 and CD19). We assume that the fact that human UCB-VSELs, like their murine BM-derived counterparts, 9 can be more efficiently expanded into the lympho-hematopoietic lineage than ESCs or inducible pluripotent stem cells shows that they are already more committed to hematopoiesis, and thus may correspond to a population of UCB-derived LT-HSCs.
These small cells isolated from human UCB highly express Oct-4, Nanog and SSEA-4 at both the mRNA and protein levels. Moreover, what is highly relevant for their ability to specify into the hematopoietic lineage, freshly isolated VSELs already express the HoxB-4 gene, which is not expressed in ESCs, but is ultimately required for their hematopoietic expansion. 21, 22 More importantly, we found that UCB-derived VSELs not only differentiate over OP9 stroma into clonogenic hematopoietic progenitors, but also into HSCs, which are able to establish human-murine chimerism in immunodeficient NOD/SCID animals. It is well known that the level of human-murine chimerism depends on several factors, such as phenotype, the number of transplanted cells or the severity of immunodeficiency in the mice employed as recipients. 23 In the case of our experiments, we transplanted trypsinized OP9 co-cultures whose activity could be influenced by the presence of the infused OP9 cells. Further studies, however, are needed to address whether murine OP9 cells home to the hematopoietic organs of immunodeficient mice, and thus may provide more favorable conditions in which human cells could expand.
Thus, our data unequivocally show that the UCB-derived population of CD45 À VSELs may differentiate into CD45 þ HSPCs and that these extremely rare cells (B10 3 /100 ml of UCB for CD45 À /GlyA À /CD133 þ /ALDH low cells and B4 Â 10 3 / 100 ml of UCB for CD45 À /GlyA À /CD133 þ /ALDH high cells) show significant hematopoietic potential.
Taking into consideration the hematopoietic potential of UCB-derived VSELs, it would be interesting to see whether the number of these cells changes in BM in aplastic anemia patients. If VSELs would be protected from damage, they might offer an alternative source of autologous HSPCs for transplantation in aplastic patients. Furthermore, we have shown that murine VSELs are highly resistant to irradiation, 9 which suggests that human VSELs could also survive myeloablative conditioning therapy for transplantation and could stimulate hematopoiesis in the recipient after unsuccessful or partial engraftment of transplanted cells. This however will also require further study. On the basis of the foregoing, we propose that VSELs are the most primitive UCB-residing population of stem cells that possess the potential to become specified into the hematopoietic lineage, and thus may share some of the characteristics of LT-HSCs. A crucial requirement for their application in the clinic is optimization of their hematopoietic specification in an OP9-free system. We also need to ascertain whether human VSELs show the same molecular signature (for example, hypomethylation of the Oct-4 promoter, modification of somatic imprinting or the presence of bivalent domains) as their murine counterparts. Furthermore, future studies are needed to compare several populations of putative UCB-derived LT-HSCs in parallel experiments to determine the similarities and differences between these cell populations.
